Bilastine is a white to off-white crystalline powder that is sparingly soluble in methylene chloride and practically insoluble in acetone. It has an assay range of 98.0% to 102.0%.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Urapidil Base is a white crystalline powder. When dissolved, it forms a clear, colorless solution that is free of particles.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Refarmed Chemicals presents Ciprofibrate, a crucial pharmaceutical material developed for clinical efficacy in managing lipid disorders. Developed with the utmost precision, Ciprofibrate is a fibrate-class drug specially formulated as a therapeutic agent to regulate high levels of cholesterol and triglycerides, factors leading to cardiovascular diseases. Our product is synthesized with rigorous compliance to quality standards, evidenced by its Good Manufacturing Practice (GMP) certification. The drug appears as a white or slightly yellow-white crystalline powder, indicative of its purity. Highly soluble in anhydrous ethanol and toluene yet practically insoluble in water, Ciprofibrate facilitates flexibility in pharmaceutical formulation, allowing for both tablet and capsule dosage forms in strengths of 100mg and 200mg. Targeting primary hypercholesterolemia (type IIa or IIb), mixed dyslipidemia, and as preventive treatment against cardiovascular events in high cholesterol patients, Ciprofibrate's composition facilitates the acceleration of cholesterol and triglyceride breakdown and removal from the body. Recommended for bi-daily intake alongside meals, the treatment's efficacy is augmented by adherence to healthy lifestyle choices, including a balanced diet and regular exercise. Safety parameters dictate careful administration especially to those with a history of gallbladder disease, and periodic liver function evaluations are advised. Contraindications include severe renal or hepatic conditions, pregnancy, breastfeeding, or known hypersensitivity to fibrates. Consultation with healthcare professionals is critical when concomitant medications are involved, particularly statins, anticoagulants, and antibiotics. Storage requirements for Ciprofibrate are straightforward — room temperature conditions away from light and moisture ensure stability. As a product from the storied catalogue of Refarmed Chemicals, now part of the DKSH Group, Ciprofibrate is accompanied by dependable documentation for Detailed and Master Files, affirming its reputable standard in pharmaceutical resources.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Refarmed Chemicals proudly presents Carbocisteine Lysine salt monohydrate, a meticulously crafted mucolytic agent essential for healthcare professionals treating patients with respiratory tract disorders. This fine, white to slightly yellow powder exhibits high-quality performance, designed to alleviate conditions like chronic bronchitis, COPD, pneumonia, and cystic fibrosis through its ability to degrade thick, viscous mucus, facilitating easier expectoration and promoting respiratory comfort. Formulated for oral administration as a soluble powder, Carbocisteine Lysine salt monohydrate ensures convenient dosing flexibility. Each sachet contains a precisely calibrated amount of the active ingredient, offering consistent therapeutic efficacy. The typical adult dosage is 750 mg thrice daily, with adjustments made to accommodate individual patient needs by healthcare providers. Quality assurance is at the heart of our corporate ethos. This product conforms to stringent standards, with every batch undergoing rigorous testing to confirm solubility, identification, pH balance, and purity. Our assay guarantees a potency range of 98.0% - 101.0%, ensuring that each dose delivers the expected therapeutic effect. Furthermore, the product's compliance with heavy metal regulations and the meticulous control of residual solvents like ethanol underline our commitment to safety. Moreover, Carbocisteine Lysine salt monohydrate accommodates a broad spectrum of patients, with sensible precautions established for those with a history of gastrointestinal issues or hypersensitivity to its constituents. This product should be used under medical supervision, especially for those with liver or kidney impairments, or during pregnancy and lactation. It is contraindicated in individuals with active peptic ulcers. Storage is straightforward—simply keep the product in a cool, dry environment below 25°C, away from light and moisture, to maintain its integrity. Available in various package sizes, this pharmaceutical offers adaptability for different clinical settings and patient requirements. Choose Carbocisteine Lysine salt monohydrate for dependable respiratory support, backed by the trusted name of Refarmed Chemicals, a company aspiring towards delivering growth in Asia and beyond.

Products still subject to third-party patent protection might be available solely for R&D purposes.